Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response
Zhang, LL; Huang, JC; Chen, XN; Pan, CX; He, Y; Su, R; Guo, DJ; Yin, SY; Wang, S; Zhou, L; Chen, JX; Zheng, SS; Qiao, YT
Zheng, SS; Qiao, YT (corresponding author), Zhejiang Univ, Sch Med, Div Hepatobiliary & Pancreat Surg, Dept Surg,Affiliated Hosp 1, Hangzhou, Peoples R China.; Zheng, SS; Qiao, YT (corresponding author), NHC Key Lab Combined Multiorgan Transplantat, Hangzhou, Peoples R China.; Chen, JX (corresponding author), Hangzhou Normal Univ, Coll Pharm, Hangzhou Sch Med, Hangzhou, Zhejiang, Peoples R China.; Chen, JX (corresponding author), Hangzhou Normal Univ Affiliated Hosp, Dept Hepatol, Hangzhou, Zhej
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021; 9 (8):
